Sarepta Therapeutics (SRPT): From Reuters this morning: Nine of th...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Sarepta Therapeutics (SRPT)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	82
Boards Moderated	0
Alias Born	11/09/2012

Re: bacc post# 1755

Tuesday, 04/16/2013 9:20:57 AM

Tuesday, April 16, 2013 9:20:57 AM

From Reuters this morning: Nine of the 10 brokerages tracked by Thomson Reuters StarMine recommend buying Sarepta shares. Their mean price target is $42; five of the analysts rate the company a "strong buy. Sell on the news is being carried to ridiculous extremes>

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SRPT News

More SRPT News

InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow